3'-o-(n-methylanthraniloyl) atp has been researched along with Myalgia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Akter, F; Andersen, JL; Antonovic, AK; Fornili, A; Jungbluth, H; Melhedegaard, E; Ochala, J; Sonne, A; Vissing, J; Witting, N; Zanoteli, E | 1 |
1 other study(ies) available for 3'-o-(n-methylanthraniloyl) atp and Myalgia
Article | Year |
---|---|
Abnormal myosin post-translational modifications and ATP turnover time associated with human congenital myopathy-related RYR1 mutations.
Topics: Adenosine Triphosphate; Humans; Muscle, Skeletal; Muscular Diseases; Mutation; Myalgia; Myosin Heavy Chains; Protein Processing, Post-Translational; Rhabdomyolysis; Ryanodine Receptor Calcium Release Channel | 2023 |